论文部分内容阅读
目的:探讨不同化疗方式联合中药及手术治疗中晚期宫颈癌的临床价值。方法:选取我院2012年3月至2015年2月收治的200例中晚期宫颈癌患者进行随机平均分组治疗,两组患者均联合中药及手术治疗,研究组患者采用超选择动脉灌注化疗,对照组采用全身静脉化疗,比较两组患者治疗后疗效情况及不良反应发生情况。结果:经治疗后,两组患者均具有较好的疗效,研究组患者有效缓解率90%显著高于对照组患者有效缓解率79%,具统计学意义(P<0.05),不良反应发生均较少,及时对症治疗后消失,两组患者发生率比较无显著差异。结论:超选择动脉灌注化疗较全身静脉化疗疗效更为显著,不良反应少,新辅助化疗方式治疗中晚期宫颈癌疗效确切,值得临床推广与研究。
Objective: To investigate the clinical value of different chemotherapy combined with traditional Chinese medicine and surgical treatment of advanced cervical cancer. Methods: A total of 200 patients with advanced cervical cancer who were treated in our hospital from March 2012 to February 2015 were randomly divided into two groups. Patients in both groups were treated with traditional Chinese medicine and surgery. Patients in the study group were treated with superselective arterial infusion chemotherapy. Group using systemic intravenous chemotherapy, the two groups were compared after treatment efficacy and adverse reactions. Results: After treatment, the two groups of patients had good curative effect. The effective response rate of 90% in study group was significantly higher than that in control group (79%), with statistical significance (P <0.05) and adverse reactions Less, timely disappear after symptomatic treatment, the incidence of the two groups no significant difference. Conclusion: Superselective arterial infusion chemotherapy is more effective than systemic vein chemotherapy, with fewer adverse reactions. Neoadjuvant chemotherapy is effective in treating advanced cervical cancer, which is worthy of clinical promotion and research.